We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other best performing growth ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has ...

JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models ...

Fintel reports that on March 3, 2025, B of A Securities downgraded their outlook for Zai Lab Limited - Depositary Receipt () ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB – Research Report), Perspective ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Zai Lab Limited - Depositary Receipt () (NasdaqGM:ZLAB ...

Shares of Zai Lab Limited Unsponsored ADR (ZLAB) have gained 15.9% over the past four weeks to close the last trading session at $31.73, but there could still be a solid upside left in the stock if ...

Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s ...

Scotiabank initiated coverage on shares of Zai Lab (NASDAQ:ZLAB – Free Report) in a research note issued to investors on ...

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688 ...